Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
CHRS holding history
Coherus Oncology, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −82,000−100.0% | Sold out | Holders |
| Q4 2024 | 82,000 | $113.2K | 0.1% | −290,000−78.0% | Reduced | Holders |
| Q3 2024 | 372,000 | $386.9K | 0.3% | +102,000+37.8% | Added | Holders |
| Q2 2024 | 270,000 | $467.1K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2024 | 270,000 | $645.3K | 0.5% | +160,000+145.5% | Added | Holders |
| Q4 2023 | 110,000 | $366.3K | 0.3% | +110,000 | New | Holders |